Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product

Author： Qureshi S.A. McGilveray I.J.

Publisher： Elsevier

ISSN： 0928-0987

Source： European Journal of Pharmaceutical Sciences, Vol.7, Iss.3, 1999-02, pp. : 249-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Typical variability and evaluation of sources of variability in drug dissolution testing

By Siewert M. Weinandy L. Whiteman D. Judkins C.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 53, Iss. 1, 2002-01 ,pp. : 9-14

Elsevier

Access to resources Recommend Favorite

Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I

By Abdel-Mottaleb Mona M.A. Lamprecht Alf

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 2, 2011-02 ,pp. : 178-184

Informa Healthcare

Access to resources Recommend Favorite

Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets

By Srinarong Parinda Kouwen Sander Visser Marinella R. Hinrichs Wouter L. J. Frijlink Henderik W.

Pharmaceutical Development and Technology, Vol. 15, Iss. 5, 2010-10 ,pp. : 460-468

Informa Healthcare

Access to resources Recommend Favorite

Using the Drug Dissolution Test for the Characterization of Generics: Ofloxacin Tablets

By Dorofeev V. L. Titov I. V. Kochin V. Yu. Arzamastsev A. P.

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 5, 2004-05 ,pp. : 264-266

Springer Publishing Company

Access to resources Recommend Favorite

In Vitro Dissolution Testing of Drug-Eluting Stents

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 1, 2013-01 ,pp. : 67-75

Bentham Science Publishers

Access to resources Recommend Favorite